Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McGarry

Showing results (161-170 of 248) with videos related to

Pageof 25
Sort By:
Lab on a Chip|February 5, 2009
A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeuticsColin L Walsh, Brett M Babin, Rachel W Kasinskas, et al.
Plos One|April 12, 2023
Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry dataLisa J McGarry, Zahra Bhaiwala, Andrea Lopez, et al.
International Journal of Geriatric Psychiatry|May 8, 2002
Mental health in older adult recipients of primary care services: is depression the key issue? Identification, treatment and the general practitionerS C Watts, G E Bhutani, I H Stout, et al.
The Journal of Trauma|December 13, 2002
Outcomes and costs of acute treatment of traumatic brain injuryLisa J McGarry, David Thompson, Frederick H Millham, et al.
Plos One|March 17, 2011
Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesisKathryn M Schultz, Ghazal Banisadr, Ruben O Lastra, et al.
Applied Health Economics and Health Policy|June 7, 2019
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid LeukemiaCarsten Hirt, Sergio Iannazzo, Silvia Chiroli, et al.
Experimental Cell Research|March 6, 2021
Organotypic platform for studying cancer cell metastasisGiulia Spennati, Lisa F Horowitz, David J McGarry, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1Marianne K-H Kim, Thomas J McGarry, Pilib O Broin, et al.
Journal of Medical Economics|February 9, 2010
Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumoniaLisa J McGarry, Sanjay Merchant, Dilip Nathwani, et al.
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|September 19, 2002
Classification system for partial edentulismThomas J McGarry, Arthur Nimmo, James F Skiba, et al.
Pageof 25

Showing results (161-170 of 248) with videos related to

Sort By:
Pageof 25
Lab on a Chip|February 5, 2009
A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeuticsColin L Walsh, Brett M Babin, Rachel W Kasinskas, et al.
Plos One|April 12, 2023
Calibration and validation of modeled 5-year survival predictions among people with cystic fibrosis treated with the cystic fibrosis transmembrane conductance regulator modulator ivacaftor using United States registry dataLisa J McGarry, Zahra Bhaiwala, Andrea Lopez, et al.
International Journal of Geriatric Psychiatry|May 8, 2002
Mental health in older adult recipients of primary care services: is depression the key issue? Identification, treatment and the general practitionerS C Watts, G E Bhutani, I H Stout, et al.
The Journal of Trauma|December 13, 2002
Outcomes and costs of acute treatment of traumatic brain injuryLisa J McGarry, David Thompson, Frederick H Millham, et al.
Plos One|March 17, 2011
Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesisKathryn M Schultz, Ghazal Banisadr, Ruben O Lastra, et al.
Applied Health Economics and Health Policy|June 7, 2019
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid LeukemiaCarsten Hirt, Sergio Iannazzo, Silvia Chiroli, et al.
Experimental Cell Research|March 6, 2021
Organotypic platform for studying cancer cell metastasisGiulia Spennati, Lisa F Horowitz, David J McGarry, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1Marianne K-H Kim, Thomas J McGarry, Pilib O Broin, et al.
Journal of Medical Economics|February 9, 2010
Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumoniaLisa J McGarry, Sanjay Merchant, Dilip Nathwani, et al.
Journal of Prosthodontics : Official Journal of the American College of Prosthodontists|September 19, 2002
Classification system for partial edentulismThomas J McGarry, Arthur Nimmo, James F Skiba, et al.
Pageof 25